Nordic Pharmacovigilance Day

Different Perspectives and New Challenges within Pharmacovigilance Regulated Activities

2023 is a special year for the yearly conference “Nordic Pharmacovigilance Day”, as it has successfully reached the 10^th edition which will be held in Copenhagen on November 16^th 2023.

It will be a full day event focused on the current and interesting topics for people working in depth with pharmacovigilance regulated activities or with any interlinking activities in e.g. related departments, in northern Europe.

Knowledgeable experts coming from pharma industry, health authorities, service providers and CROs, will share their experiences and will be available for discussion and questions.

The aim of this conference is to bring the learning opportunity for pharmacovigilance professionals to  discuss, interact, actively participate and get inspired from the speakers as well as from each other.

Considering that the expectation covering pharmacovigilance is quickly evolving within several different areas, the agenda of the conference will offer different perspectives from e.g. regulators, insights from partners and providers, and presenting examples from both small and big pharma companies.

The talks will focus on:

• Regulatory processes in pharmacovigilance activities
• Early experiences of the EU CTR n.536/2014
• Optimization of pharmacovigilance processes
• Handling of new sources of safety information
• Globalization of PSMF
• Learnings from PV audits – internal activities and external vendors
• Medical Devices: vigilance and signal detection
• Combination products: challenges and solutions

Would you like to attend? Don’t forget to register in advance to secure your seat at the Early Bird fee. It will be a pleasure to celebrate the 10^th anniversary of the Nordic Pharmacovigilance Day together.

Scientific Board

• Wasim Anwar - Vice President & Deputy QPPV - Head of QPPV Office, Global Safety at Novo Nordisk A/S
• Caroline Susanne Sandström - Head of Global Clinical Quality at Ferring Pharmaceuticals A/S
• Mette Stie Kallesøe - Head of Pharmacovigilance, QPPV at Hansa Biopharma AB

Who should attend?
The conference program is designed for healthcare professionals or pharmacists working in the pharmacovigilance units in the pharmaceutical industry or regulatory agencies, either as specialists or managers, QPPVs, inspectors and QA personnel including auditors, employees in regulatory affairs units with close relations to pharmacovigilance, vendors and CROs working with patient safety data.